
    
      It will explore the tolerability (phase I) and effectiveness (phase II) of the Donafenib
      tosilate tablets combined with Toripalimab injection in patients with advanced HCC. The study
      is conducted in two phases, the first phase is the dose exploration phase (phase I), and the
      second phase is the dose expansion phase (phase II).
    
  